miRNAシーケンシングおよびアッセイの世界市場予測（～2024年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 13
1.1 OBJECTIVES OF THE STUDY 13
1.2 MARKET DEFINITION 13
1.3 MARKET SCOPE 13
1.3.1 MARKETS COVERED 14
1.3.2 YEARS CONSIDERED FOR THE STUDY 14
1.4 CURRENCY 15
1.5 STAKEHOLDERS 15
1.6 LIMITATIONS 15
2 RESEARCH METHODOLOGY 16
2.1 RESEARCH APPROACH 16
2.1.1 SECONDARY RESEARCH 16
2.1.1.1 Key data from secondary sources 17
2.1.2 PRIMARY RESEARCH 17
2.1.2.1 Key data from primary sources 18
2.1.2.2 Break down of primaries 18
2.1.2.3 Key industry insights 19
2.2 MARKET SIZE ESTIMATION 19
2.3 DATA TRIANGULATION APPROACH 21
2.4 ASSUMPTIONS FOR THE STUDY 22
3 EXECUTIVE SUMMARY 23
4 PREMIUM INSIGHTS 26
4.1 MIRNA SEQUENCING & ASSAYS MARKET OVERVIEW 26
4.2 MIRNA SEQUENCING & ASSAYS MARKET, BY TECHNOLOGY (2016–2024) 27
4.3 NORTH AMERICA: MIRNA SEQUENCING & ASSAYS MARKET, BY PRODUCT (2018) 28
5 MARKET OVERVIEW 29
5.1 INTRODUCTION 29
5.2 MARKET DYNAMICS 29
5.2.1 MARKET DRIVERS 30
5.2.1.1 Advantages of miRNA sequencing over other technologies 30
5.2.1.2 Increasing research funding for genomics 30
5.2.1.3 Decreasing cost of sequencing 31
5.2.2 MARKET OPPORTUNITIES 32
5.2.2.1 Increasing focus on miRNA biomarker discovery 32
 
5.2.3 MARKET CHALLENGES 32
5.2.3.1 Dearth of skilled professionals 32
6 MIRNA SEQUENCING AND ASSAYS MARKET, BY PRODUCT 33
6.1 INTRODUCTION 34
6.2 SEQUENCING CONSUMABLES 34
6.2.1 INCREASING DEMAND FOR MIRNA SEQUENCING IS BOOSTING THE ADOPTION OF SEQUENCING CONSUMABLES 34
6.3 LIBRARY PREPARATION KITS 36
6.3.1 LIBRARY PREPARATION KITS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 36
7 MIRNA SEQUENCING AND ASSAYS MARKET, BY TECHNOLOGY 38
7.1 INTRODUCTION 39
7.2 SEQUENCING BY SYNTHESIS 39
7.2.1 SEQUENCING BY SYNTHESIS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2018 39
7.3 ION SEMICONDUCTOR SEQUENCING 41
7.3.1 PLATFORMS DEVELOPED USING THIS TECHNOLOGY ARE LOW-COST INSTRUMENTS AND POSSESS HIGH-THROUGHPUT CAPABILITIES 41
7.4 SEQUENCING BY OLIGONUCLEOTIDE LIGATION AND DETECTION 43
7.4.1 SOLID SEQUENCING OFFERS ACCURATE SEQUENCING OF SHORT READS 43
7.5 NANOPORE SEQUENCING 44
7.5.1 NANOPORE SEQUENCING SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 44
8 MIRNA SEQUENCING AND ASSAYS MARKET, BY END USER 46
8.1 INTRODUCTION 47
8.2 RESEARCH AND ACADEMIC INSTITUTES 47
8.2.1 RESEARCH AND ACADEMIC INSTITUTES SEGMENT TO DOMINATE THIS SEGMENT 47
8.3 CONTRACT RESEARCH ORGANIZATIONS 49
8.3.1 CONTRACT RESEARCH ORGANIZATIONS SUCH AS GENOMICS SERVICES COMPANIES TO GROW AT HIGHEST CAGR” 49
9 MIRNA SEQUENCING AND ASSAYS MARKET, BY REGION 51
9.1 INTRODUCTION 52
9.2 NORTH AMERICA 53
9.2.1 US 55
9.2.1.1 US dominates the north american miRNA sequencing and assays market, due to the favorable funding scenario for research and strong presence of key market players 55
9.2.2 CANADA 57
9.2.2.1 Increase in genomics research to drive the adoption of mirna sequencing in Canada 57
9.3 EUROPE 59
9.3.1 GERMANY 62
9.3.1.1 Growth of the genomics market to drive the growth of the market growth 62
9.3.2 UK 64
9.3.2.1 Government initiatives in genomics to drive the market for mirna sequencing 64
9.3.3 ROE 65
9.4 ASIA PACIFIC 67
9.5 REST OF THE WORLD 69
10 COMPETITIVE LANDSCAPE 71
10.1 OVERVIEW 71
10.2 VENDOR BENCHMARKING 71
10.3 COMPETITIVE LEADERSHIP MAPPING 71
10.3.1 VISIONARY LEADERS 71
10.3.2 INNOVATORS 71
10.3.3 DYNAMIC DIFFERENTIATORS 71
10.3.4 EMERGING COMPANIES 71
10.4 MARKET RANKING ANALYSIS, 2017 73
10.5 COMPETITIVE SITUATION AND TRENDS 74
10.5.1 COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS 74
10.5.2 PRODUCT LAUNCHES 75
10.5.3 ACQUISITIONS 75
11 COMPANY PROFILES 76
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 ILLUMINA, INC. 76
11.2 THERMO FISHER SCIENTIFIC 78
11.3 QIAGEN 80
11.4 PERKINELMER, INC. 82
11.5 TAKARA BIO, INC. 84
11.6 NEW ENGLAND BIOLABS, INC. 87
11.7 NORGEN BIOTEK CORPORATION 88
11.8 TRILINK BIOTECHNOLOGIES 89
11.9 LEXOGEN 90
11.10 OXFORD NANOPORE TECHNOLOGIES 91

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
 
12 APPENDIX 92
12.1 DISCUSSION GUIDE 92
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 95
12.3 AVAILABLE CUSTOMIZATIONS 97
12.4 RELATED REPORTS 97
12.5 AUTHOR DETAILS 98